Roundhill Magnificent Seven ETF vs Progressive Corp — how do they compare? Roundhill Magnificent Seven ETF trades at $68.66, while Progressive Corp trades at $211.8 (market cap $124.38B). The key difference: Progressive Corp pays a 6.5% dividend while Roundhill Magnificent Seven ETF pays none, and Roundhill Magnificent Seven ETF is trading nearer its 52-week high, Progressive Corp nearer its low. Which is the better fit depends on your goals.
| MAGS | PGR | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $70.94 | $252.68 |
52-Week Low | $55.39 | $190.40 |
Market Cap | — | $124.38B |
Enterprise Value | — | $132.59B |
Dividend Yield | — | 6.5% |
Signals from Pluang's Aura AI — not financial advice
MAGS trades at $69.07, up 0.71% today, with a bullish technical signal from moving averages but neutral oscillators. Recent news highlights underperformance versus the S&P 500 and concerns over AI spending pressure on big tech balance sheets. The ETF has gained 181% since launch but faces challenges from equal-weighted concentration in the Magnificent Seven stocks.
The outlook is mixed: technical strength supports near-term upside, but fundamental risks from high AI capital expenditure and shifting investor sentiment toward broader market exposure pose headwinds. Investment opportunity hinges on AI revenue growth outpacing costs, while key risks include sector rotation and valuation compression.
No Aura AI signal available yet.
Trailing returns across standard periods
MAGS is an ETF that provides concentrated exposure to the seven technology-focused mega-cap companies often referred to as the 'Magnificent Seven' (Alphabet, Amazon, Apple, Meta, Microsoft, NVIDIA, and Tesla). The fund is designed to capture the performance of these market-leading stocks, which have been the primary drivers of market returns. It offers a simple way for investors to invest solely in this select group of high-growth technology companies.
Read more on MAGS →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →